Sabitlenmiş Tweet
New: Here’s our latest primer on 10 of the top clinical trials to watch in #biotech over the next 6 months, and why you should keep an eye on them:
biopharmadive.com/news/biotech-p… $XBI $IBB
English
Ben Fidler
8.6K posts
Ben Fidler
@BentheFidler
Biotech Journalist; Lead Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy.
Virginia Katılım Nisan 2013
673 Takip Edilen8.5K Takipçiler
GSK shelves cough drug acquired in $2B deal biopharmadive.com/news/gsk-camli… @ByJonGardner $GSK $MRK $BAYRY $TRVI + 11%
English
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics biopharmadive.com/news/lilly-ata… by @realJacobBell $ATAI + 34% $GHRS + 11% $CMPS $HELP + 9%
English
Merck wins first approval of a PCSK9 cholesterol pill biopharmadive.com/news/merck-lip… $MRK + 2% $AMGN $NVS $REGN $AZN
English
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals biopharmadive.com/news/jnj-earni… $JNJ $AZN $SPRO $SMMT $XBI
English
Braveheart, Attovia join next wave of #biotech IPOs biopharmadive.com/news/attovia-b… by @gwendolynawu $ATTO $BRVE $BMY $CYTK
English
Merck ADC, in China study, shows potential to replace chemo in lung cancer biopharmadive.com/news/merck-sac… by Kristin Jensen $MRK + 2%
English
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill biopharmadive.com/news/avere-nex… @ByJonGardner $AKRO $NXTC + 202% $PTGX $JNJ
English
Judge orders Apple Tree partner to forfeit oversight of venture fund (but US court hasn't yet recognized the ruling) biopharmadive.com/news/apple-tre… by @gwendolynawu #biotech #startups
English
New, from @realJacobBell: Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs biopharmadive.com/news/biogen-al… $BIIB + 5% $IONS #AAIC26
English
Q32 bounces back to claim study success for alopecia drug biopharmadive.com/news/q32-bempi… @ByJonGardner $QTTB + 95% $NKTR
English
Agenus surges on study pivot; Apnimed lines up an IPO biopharmadive.com/news/agenus-su… $AGEN + 92% $APMD $BMY $PFE
English
New, from @gwendolynawu: A funding gap is growing amid a broader rebound in venture financing for #biotech startups.
biopharmadive.com/news/biotech-v…
English
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership biopharmadive.com/news/biohaven-… $BHVN $TARS $CMMB
English
Ben Fidler retweetledi
1. RNAi is not ASO
2. TTR Kd with Vutri > Eplon…
Nucre>>Eplon
3. HR for Taf + Vutri vs. Taf is 0.66 in HELIOS-B
4. HR for Taf + Eplon vs. Taf is likely >1.0 (!!) in CardioTTRansform (inferred based on 0.71 monotherapy HR and 81% of patients on stabilizer)… ASO creating harm?
Ronald Witteles@Ron_Witteles
The main issue: Stabilizers are really good therapies! We have not known the clear answer to the 'combination therapy' question despite a favorable signal with tafamidis +/- vutrisiran in HELIOS-B (mortality curves shown below).
English
Roche scraps two Ionis-partnered Huntington’s drugs biopharmadive.com/news/roche-tom… @ByJonGardner $RHHBY $IONS $QURE
English
AstraZeneca, Ionis drug fails big heart disease study in major setback biopharmadive.com/news/astrazene… $AZN - 8% $IONS - 21% $ALNY + 18% $BBIO + 10%
English
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal biopharmadive.com/news/prime-bea… $PRME + 16% $BEAM - 3% $RVMD $XBI
English
Vera Therapeutics wins FDA nod for closely watched kidney disease drug biopharmadive.com/news/vera-fda-… by @Lilah_Alvarado $VERA + 7% $VRTX $BIIB $NVS
English
Kailera says obesity pill succeeds in late-stage trial in China biopharmadive.com/news/kailera-h… @ByJonGardner $KLRA - 9% $LLY $NVO
English
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs biopharmadive.com/news/vertex-cr… $VRTX - 2% $CRNX $NBIX $NVS
English